Correlation of Biomarkers in Severe COVID-19 Patients Cross-sectional Study

BACKGROUND: In patients with coronavirus disease-19 (COVID-19), serious biomarkers (liver function tests and renal functions tests) (urea, creatinine, GOT, GPT, LDH) are determined immediate to assess in prognosis of the severity disease. AIM: The aim study was determine correlation between among COVID-19 patients. METHODS: A cross-sectional study, a total 90 who attending Al-Hussein Medical City Karbala, Iraq, participated present within month’s time late December 2021 early January 2022. All positive SARS-COV-2 real-time RT-PCR results were reviewed. classifying according SPO2 into three groups (mild, moderate, severe groups). demographic data (sex, age, SPO2) collected while for all done by bio-base instrument (ACCENT-200 ALAT KIT). RESULTS: white blood cell “WBC” neutrophil moderate had substantially greater counts (p = 0.005) when compared mild group lymphocytes considerably decreased 0.005). group, there significant neutrophils serum LDH (r 0.451*, p 0.014). There no liver tests. Furthermore, patient strong positively correlating notably LDH. Moreover, concentration 0.05, 0.08, 0.5) higher levels groups, on other hand, (urea creatinine) high than groups. CONCLUSION: urea, GOPT, although statistically ALP, urea patient’s group). found test).